Financhill
Buy
52

CPIX Quote, Financials, Valuation and Earnings

Last price:
$3.88
Seasonality move :
0.52%
Day range:
$3.71 - $3.95
52-week range:
$1.85 - $7.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.38x
P/B ratio:
2.21x
Volume:
126.4K
Avg. volume:
231.2K
1-year change:
-14.6%
Market cap:
$57.7M
Revenue:
$37.9M
EPS (TTM):
-$0.23

Earnings Data

Next earnings date for CPIX
Mar 03
2026
Most recent earnings per share
-$0.13
Missed by $0.13
(Nov 4/2025)
Consensus Estimate
--
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CPIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/04/2025 Q3 -- $8.3M -$0.13 -- --
08/05/2025 Q2 -- $10.8M -$0.05 -- --
05/06/2025 Q1 -- $11.7M $0.08 -- --
03/04/2025 Q4 -- $10.4M -$0.14 -- --
11/07/2024 Q3 -- $9.1M -$0.11 -- --
08/06/2024 Q2 -- $9.8M -$0.08 -- --
05/07/2024 Q1 -- $8.5M -$0.14 -- --
03/05/2024 Q4 -- $9.4M -$0.44 -- --
11/07/2023 Q3 -- -- -$0.07 -- --
06/30/2023 Q2 -- -- $0.06 -- --
03/31/2023 Q1 -- -- $0.01 -- --
03/07/2023 Q4 -- -- -$0.17 -- --
11/08/2022 Q3 -- -- -$0.03 -- --
08/09/2022 Q2 -- -- -$0.09 -- --
05/10/2022 Q1 -- -- -$0.09 -- --
03/08/2022 Q4 -- -- -$0.26 -- --
11/09/2021 Q3 -- -- -$0.07 -- --
08/10/2021 Q2 -- -- $0.08 -$0.07 $0.15
05/11/2021 Q1 -- -- $0.01 -$0.07 $0.08
03/09/2021 Q4 -- -- -$0.06 -$0.01 -$0.05
11/10/2020 Q3 -- -- -$0.03 -$0.07 $0.04
08/11/2020 Q2 -- -- -$0.06 $0.03 -$0.09
05/20/2020 Q1 -- -- -$0.07 $0.02 -$0.09
03/18/2020 Q4 -- -- -$0.06 $0.01 -$0.07
11/12/2019 Q3 -- -- -$0.13 $0.11 -$0.24
08/14/2019 Q2 -- -- -$0.04 $0.07 -$0.11
05/14/2019 Q1 -- -- -- -$0.11 --
02/26/2019 Q4 -- -- -$0.14 -$0.16 $0.02
11/13/2018 Q3 -- -- -$0.11 -- --
08/14/2018 Q2 -- -- -$0.05 -- --
05/08/2018 Q1 -- -- -$0.15 -- --
03/06/2018 Q4 -- -- -$0.05 -- --
11/07/2017 Q3 -- -- -$0.05 -- --
08/08/2017 Q2 -- -- -$0.32 -- --
05/15/2017 Q1 -- -- -$0.08 -- --
03/07/2017 Q4 -- -- -$0.05 -- --
11/01/2016 Q3 -- -- $0.01 -- --
08/02/2016 Q2 -- -- -$0.00 -- --
05/10/2016 Q1 -- -- -$0.02 -- --

Cumberland Pharmaceuticals, Inc. Earnings Questions

  • How Much did Cumberland Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Cumberland Pharmaceuticals, Inc. reported $8.3M worth of top line sales in its most recent quarter.

  • Did Cumberland Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Cumberland Pharmaceuticals, Inc. announced earnings per share of -$0.13 which represents a miss of analyst forecast a -- per share.

  • Is Cumberland Pharmaceuticals, Inc. Profitable?

    Cumberland Pharmaceuticals, Inc. reported $6.3M that represents $0.42 per share over the last quarter.

  • What is the Analyst Consensus for Cumberland Pharmaceuticals, Inc. EPS Next Year?

    Cumberland Pharmaceuticals, Inc.'s earnings are forecast to grow from -$0.46 per share to -- per share next year representing an increase of --.

  • When is Cumberland Pharmaceuticals, Inc.'s Earnings Date?

    Cumberland Pharmaceuticals, Inc.'s next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
48
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 29x

Alerts

Buy
73
NKTR alert for Feb 11

Nektar Therapeutics [NKTR] is up 12.71% over the past day.

Buy
53
ICHR alert for Feb 11

Ichor Holdings Ltd. [ICHR] is up 1.26% over the past day.

Sell
26
MEDP alert for Feb 11

Medpace Holdings, Inc. [MEDP] is down 3.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock